Temodal
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Temodal, covering 2013-01-08 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Temodal (temozolomide) — Merck Sharp & Dohme B.V.
5 regulatory and trial events tracked for Temodal, covering 2013-01-08 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Temodal (temozolomide) — Merck Sharp & Dohme B.V.